Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations AMTM Q1 2026 Earnings EPS Beats Estimates Stock Rises 293 FRHC Q1 2026 Earnings Strong EPS Performance Despite Market Headwinds HYNE Q1 2026 Earnings Net Loss of 002 Per Share as Stock Declines HYFM Q3 2025 Earnings Significant EPS Miss Highlights Ongoing Challenges Rapid7 RPD Q1 2026 Earnings EPS Surges Past Estimates as Cybersecurity Demand Remains Strong